TY - JOUR
T1 - Correction to
T2 - Efficacy, safety and drug survival of thioguanine as maintenance treatment for inflammatory bowel disease: a retrospective multi-centre study in the United Kingdom (BMC Gastroenterology, (2020), 20, 1, (296), 10.1186/s12876-020-01441-6)
AU - Bayoumy, Ahmed B.
AU - van Liere, Elsa L.S.A.
AU - Simsek, Melek
AU - Warner, Ben
AU - Loganayagam, Aathavan
AU - Sanderson, Jeremy D.
AU - Anderson, Simon
AU - Nolan, Jonathan
AU - de Boer, Nanne K.
AU - Mulder, Chris J.J.
AU - Ansari, Azhar
N1 - Publisher Copyright: © 2022, The Author(s).
PY - 2022/12
Y1 - 2022/12
N2 - After publication of this article [1], the authors reported three adjustments: 1. Competing interests: the travel grants were paid by HLW Pharma instead of TEVA Pharma. 2. TGN-units all over the manuscript have to be adjusted from pmol/8 × 105 RBC to pmol/8 × 108 RBC. 3. Some minor textual adjustments. The original article [1] has been updated.
AB - After publication of this article [1], the authors reported three adjustments: 1. Competing interests: the travel grants were paid by HLW Pharma instead of TEVA Pharma. 2. TGN-units all over the manuscript have to be adjusted from pmol/8 × 105 RBC to pmol/8 × 108 RBC. 3. Some minor textual adjustments. The original article [1] has been updated.
UR - http://www.scopus.com/inward/record.url?scp=85128963671&partnerID=8YFLogxK
U2 - https://doi.org/10.1186/s12876-021-01992-2
DO - https://doi.org/10.1186/s12876-021-01992-2
M3 - Comment/Letter to the editor
C2 - 35473670
SN - 1471-230X
VL - 22
JO - BMC gastroenterology
JF - BMC gastroenterology
IS - 1
M1 - 208
ER -